Skip to content
HowShorted

Tvardi Therapeutics, Inc. short interest in 2019

In 2019, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 13.39% of shares outstanding on 15 Jan 2019 to 11.51% on 31 Dec 2019, a change of -1.88 percentage points. The year's high was 16.12% on 28 Jun 2019 and its low 11.51% on 31 Dec 2019, averaging 13.65% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.64 days on 31 Oct 2019. Full history: Tvardi Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tvardi Therapeutics, Inc. in 2019

2019 in figures

Start of year
13.39% (15 Jan 2019)
End of year
11.51% (31 Dec 2019)
Change
-1.88 pp
High
16.12% (28 Jun 2019)
Low
11.51% (31 Dec 2019)
Average
13.65%
Highest days to cover
17.64 (31 Oct 2019)
SEC filings marked
9

Every report in 2019

Tvardi Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201913.39%6.71
31 Jan 201913.44%10.94
15 Feb 201913.46%8.63
28 Feb 201913.88%10.53
15 Mar 201913.80%5.8110-K filed, results (8-K)
29 Mar 201913.44%10.21
15 Apr 201913.94%8.64
30 Apr 201915.23%8.47
15 May 201915.01%8.1210-Q filed, results (8-K)
31 May 201915.61%4.79
14 Jun 201915.70%10.37
28 Jun 201916.12%10.47
15 Jul 201915.98%8.14
31 Jul 201915.13%4.52results (8-K)
15 Aug 201912.46%8.2810-Q filed, results (8-K)
30 Aug 201913.27%11.49
13 Sep 201912.90%11.17
30 Sep 201912.22%5.78
15 Oct 201912.12%9.81
31 Oct 201912.17%17.64
15 Nov 201912.80%14.1410-Q filed, results (8-K)
29 Nov 201912.35%10.02
13 Dec 201911.60%3.76
31 Dec 201911.51%8.06

See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.